First we had GLP-1s that not only help people lose weight and manage diabetes, but have since been found to help with other conditions even if those taking them don’t slim down.
Now scientists are exploring various uses for another drug, which it is hoped will prove to be an ‘Ozempic for the brain’, able to target several brain-related conditions.
GLP-1 agonist drugs work by mimicking the action of the hormone glucagon-like peptide-1 (GLP-1), which is released after we eat.
The new drug is designed to boost levels of another peptide, orexin, a kind of chemical messenger made in a part of the
To provide well-rounded coverage and a breadth of insight across various events, we rely on contributions from several staff writers, each bringing their own area of expertise to our publication.